CN108344608B - 一种快速微波病理组织处理专用试剂及其制备方法 - Google Patents
一种快速微波病理组织处理专用试剂及其制备方法 Download PDFInfo
- Publication number
- CN108344608B CN108344608B CN201810133068.5A CN201810133068A CN108344608B CN 108344608 B CN108344608 B CN 108344608B CN 201810133068 A CN201810133068 A CN 201810133068A CN 108344608 B CN108344608 B CN 108344608B
- Authority
- CN
- China
- Prior art keywords
- parts
- solution
- liquid
- prepared
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001575 pathological effect Effects 0.000 title claims abstract description 120
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 88
- 238000002360 preparation method Methods 0.000 title claims abstract description 50
- 239000007788 liquid Substances 0.000 claims abstract description 122
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 110
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 102
- -1 alcohol compound Chemical class 0.000 claims abstract description 67
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims abstract description 56
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 36
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 36
- 229930195729 fatty acid Natural products 0.000 claims abstract description 36
- 239000000194 fatty acid Substances 0.000 claims abstract description 36
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 36
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 36
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 36
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 229960001047 methyl salicylate Drugs 0.000 claims abstract description 28
- 210000001519 tissue Anatomy 0.000 claims description 110
- 238000001574 biopsy Methods 0.000 claims description 44
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 38
- 238000003756 stirring Methods 0.000 claims description 26
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical group CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 25
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 24
- 238000005303 weighing Methods 0.000 claims description 24
- 210000002307 prostate Anatomy 0.000 claims description 22
- 210000000481 breast Anatomy 0.000 claims description 21
- 210000004072 lung Anatomy 0.000 claims description 21
- 210000001685 thyroid gland Anatomy 0.000 claims description 21
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 20
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 18
- 210000004185 liver Anatomy 0.000 claims description 17
- 210000001672 ovary Anatomy 0.000 claims description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 claims description 12
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 11
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 11
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 11
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 10
- 229940078546 isoeicosane Drugs 0.000 claims description 10
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 10
- 229960000583 acetic acid Drugs 0.000 claims description 9
- 239000012362 glacial acetic acid Substances 0.000 claims description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000007598 dipping method Methods 0.000 claims description 4
- 238000010827 pathological analysis Methods 0.000 abstract description 14
- 230000007613 environmental effect Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 18
- 238000004043 dyeing Methods 0.000 description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 210000005075 mammary gland Anatomy 0.000 description 8
- 230000008602 contraction Effects 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 239000012188 paraffin wax Substances 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- 239000008096 xylene Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 4
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 4
- 238000012317 liver biopsy Methods 0.000 description 4
- 230000002611 ovarian Effects 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
- G01N2001/307—Fixative compositions non-toxic, no Hg, no formaldehyde
Abstract
Description
实施例 | 快速微波病理组织处理专用试剂的制备耗时(min) | 病理切片制备至拿到诊断结果耗时(h) |
实施例1 | 33 | 2.25 |
实施例2 | 38 | 2.33 |
实施例3 | 41 | 2.08 |
实施例4 | 46 | 2.42 |
实施例5 | 40 | 2 |
实施例6 | 45 | 2.33 |
实施例7 | - | 72 |
项目 | 实施例5 | 实施例7 |
切片裂痕 | 切片完整,无裂痕 | 切片完整、无裂痕 |
硬度 | 硬度适中 | 硬度较大 |
组织收缩情况 | 组织无明显收缩 | 组织无明显收缩 |
颜色 | 染色鲜艳 | 染色鲜艳 |
结构及层次 | 结构清晰、层次分明 | 结构清晰、层次分明 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810133068.5A CN108344608B (zh) | 2018-02-09 | 2018-02-09 | 一种快速微波病理组织处理专用试剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810133068.5A CN108344608B (zh) | 2018-02-09 | 2018-02-09 | 一种快速微波病理组织处理专用试剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108344608A CN108344608A (zh) | 2018-07-31 |
CN108344608B true CN108344608B (zh) | 2021-06-22 |
Family
ID=62960148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810133068.5A Active CN108344608B (zh) | 2018-02-09 | 2018-02-09 | 一种快速微波病理组织处理专用试剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108344608B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111380735B (zh) * | 2018-12-28 | 2022-08-23 | 哈尔滨格林标本技术开发有限公司 | 一种高效环保生物组织处理液及其处理组织切片方法 |
CN110973117B (zh) * | 2019-12-23 | 2021-11-23 | 苏州堪赛尔医学检验有限公司 | 一种大鼠眼球组织细胞固定液及其制备方法、应用方法 |
CN111982626B (zh) * | 2020-08-20 | 2023-07-25 | 江苏瑞思坦生物科技有限公司 | 一种软骨球快速石蜡切片鉴定方法 |
WO2024013606A1 (en) * | 2022-07-12 | 2024-01-18 | Diapath S.P.A. | Method for preparing biological, histological, autopsical, cytological samples and composition therefor |
WO2024013605A1 (en) * | 2022-07-12 | 2024-01-18 | Diapath S.P.A. | Improved composition for the treatment of biological, cytological, histological and autopsical samples |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1005633B1 (en) * | 1997-08-20 | 2008-09-03 | The University Of Miami | A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method |
CN105300753A (zh) * | 2015-09-10 | 2016-02-03 | 山东骏腾医疗科技有限公司 | 一种用于病理切片的快速组织处理试剂 |
CN106370491A (zh) * | 2016-08-30 | 2017-02-01 | 河南新大阳生物技术有限公司 | 环保透明脱蜡液及其制备方法和其在病理切片制备中的应用 |
CN107490506A (zh) * | 2017-08-02 | 2017-12-19 | 扬州市第人民医院 | 病理诊断用试剂盒及组织片的快速处理技术 |
-
2018
- 2018-02-09 CN CN201810133068.5A patent/CN108344608B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1005633B1 (en) * | 1997-08-20 | 2008-09-03 | The University Of Miami | A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method |
CN105300753A (zh) * | 2015-09-10 | 2016-02-03 | 山东骏腾医疗科技有限公司 | 一种用于病理切片的快速组织处理试剂 |
CN106370491A (zh) * | 2016-08-30 | 2017-02-01 | 河南新大阳生物技术有限公司 | 环保透明脱蜡液及其制备方法和其在病理切片制备中的应用 |
CN107490506A (zh) * | 2017-08-02 | 2017-12-19 | 扬州市第人民医院 | 病理诊断用试剂盒及组织片的快速处理技术 |
Non-Patent Citations (1)
Title |
---|
Histology without xylene;René J. Buesa, BSc, et al.;《Annals of Diagnostic Pathology》;20091231(第13期);第250页右栏第3段-第251页右栏第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN108344608A (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108344608B (zh) | 一种快速微波病理组织处理专用试剂及其制备方法 | |
CN108387421B (zh) | 一种用于病理切片的新型环保快速组织处理液 | |
Chen et al. | Utilization of isoflavones in soybeans for women with menopausal syndrome: an overview | |
Negahdari et al. | Wound healing activity of extracts and formulations of aloe vera, henna, adiantum capillus-veneris, and myrrh on mouse dermal fibroblast cells | |
Callow et al. | Methods of extracting compounds related to the steroid hormones from human urine | |
Chi et al. | The causative pathogens of onychomycosis in southern Taiwan | |
Liu et al. | Supercritical carbon dioxide extraction of ethyl p-methoxycinnamate from Kaempferia galanga L. rhizome and its apoptotic induction in human HepG2 cells | |
CN105300753A (zh) | 一种用于病理切片的快速组织处理试剂 | |
Kotepui et al. | Epidemiology and histopathology of benign breast diseases and breast cancer in southern Thailand. | |
Pickler et al. | Effect of Libidibia ferrea bark and seed in maternal reproductive and biochemical outcomes and fetal anomaly in rats | |
CN103994913A (zh) | 用于骨髓活检的固定-脱钙液及骨髓活检组织石蜡切片方法 | |
CN108387419A (zh) | 一种新型环保快速生物组织处理液 | |
CN103505445B (zh) | 二甲双胍的用途 | |
CN103349670A (zh) | 日本血吸虫卵提取物在制备抗肝纤维化药物中的应用 | |
Cappilli et al. | Sharpen your sight: Trombiculosis under the dermatoscope with LC‐OCT new insights. | |
Stone | Effect of processing on measurements of Heterodera rostochiensis larvae | |
Çelik et al. | Determination of genotoxic and antigenotoxic effects of wild-grown Reishi mushroom (Ganoderma lucidum) using the hen’s egg test for analysis of micronucleus induction | |
Davidson et al. | A clinical and mycological study of suppurative ringworm | |
Yin et al. | Inhibitory activity of the ethyl acetate fraction from Viscum coloratum on bone resorption | |
Abhitha et al. | An observational clinico etiological study of Kushta with specific reference to Tinea corporis | |
CN108403531A (zh) | 香青兰提取物在制备美白祛斑化妆品中的用途 | |
Vui et al. | Investigation of the estrogenic activity of Pueraria candollei variety mirifica extract on rats. | |
Parveen | Concept of therapeutic approach of superficial dermatophytosis in unani medicine | |
Terent'eva et al. | Species spectrum of bacteria of genus clostridium isolated from cattle on dig dairy farms | |
Akbar et al. | Dermatophytes Isolation from Patients and In-vitro Application of Selected Natural Extracts and Oils for Anti-Dermatophytic Activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: He Jun Inventor after: Li Jienan Inventor after: Li Xiqi Inventor after: Xu Tingxiang Inventor after: Wu Pinzuo Inventor after: Wang Haiyang Inventor after: Xu Dapeng Inventor after: Wei Fangfang Inventor before: Li Jienan Inventor before: He Jun Inventor before: Li Xiqi Inventor before: Xu Tingxiang Inventor before: Wu Pinzuo Inventor before: Wang Haiyang Inventor before: Xu Dapeng Inventor before: Wei Fangfang |
|
GR01 | Patent grant | ||
GR01 | Patent grant |